Generated by AI
Catheter Precision, Inc. is a dynamic player in the medical technology sector, specializing in the development and commercialization of advanced catheters and related technologies. The company focuses on providing innovative solutions for electrophysiology, a branch of cardiology that examines and treats arrhythmias. Their products are designed to support physicians in diagnosing and treating heart rhythm disorders with precision and efficacy. Notable features of Catheter Precision’s offerings include cutting-edge technology that enhances the accuracy of cardiac interventions and improves patient outcomes. As part of the broader healthcare sector, the company contributes to advancing medical treatments and has a significant impact on the quality of care provided to patients with cardiac issues. By continually innovating and integrating state-of-the-art technologies, Catheter Precision plays a crucial role in the electrophysiology market, offering tools that empower healthcare professionals to deliver superior cardiac care.
Website1670 Highway 160 West
Fort Mill, SC, 29708
United States
The latest articles about VTAK.
FORT MILL, S.C, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, a wholly owned subsidiary of Flyte Aviation, Inc. (NYSE American: VJET), today announced the first published comparative study evaluating its LockeT suture retention device against a traditional internal vascular closure device (VCD) following large bore venous access. The 172-patient peer-reviewed study, titled "Vascular closure with a suture retention device versus suture-mediated closure system after large bore venous acces
Detailed price information for Flyte Aviation Inc (VJET-A) from The Globe and Mail including charting and trades.
Summary of Oct 5's posts. Generated by AI.
Summary of Aug 11's posts. Generated by AI.
Summary of Oct 5's posts. Generated by AI.
Investors talking about VTAK also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.